loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 203246 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 FLUDEOXYGLUCOSE F-18 (2)

filter

01 UNIV TX MD ANDERSON (2)

filter

01 INJECTABLE;INTRAVENOUS (2)

filter

01 20-150mCi/ML (1)

02 20-300mCi/ML (1)

filter

01 USA (2)

URL Supplier Web Content
INJECTABLE;INTRAVENOUS
20-150mCi/ML
FLUDEOXYGLUCOSE F18
USA
203246
2014-01-13
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
INJECTABLE;INTRAVENOUS
20-300mCi/ML
FLUDEOXYGLUCOSE F18
USA
203246
2014-01-13
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 203246

Looking for CTD TGA MCC DOSSIER APPLICATION 203246 2

19

The University of Texas MD Anderson Cancer Center, based in U.S.A, is a pharmaceutical company.

One of their notable products is FLUDEOXYGLUCOSE F-18, with a corresponding application number 203246 and regulatory information .

proudly manufactured in the

approval since 2014-01-13

The University of Texas MD Anderson Cancer Center's FLUDEOXYGLUCOSE F18 INJECTABLE;INTRAVENOUS, medication with 20-150mCi/ML of FLUDEOXYGLUCOSE F-18.

18

The University of Texas MD Anderson Cancer Center, based in U.S.A, is a pharmaceutical company.

One of their notable products is FLUDEOXYGLUCOSE F-18, with a corresponding application number 203246 and regulatory information .

proudly manufactured in the

approval since 2014-01-13

The University of Texas MD Anderson Cancer Center's FLUDEOXYGLUCOSE F18 INJECTABLE;INTRAVENOUS, medication with 20-300mCi/ML of FLUDEOXYGLUCOSE F-18.

Post Enquiry
POST ENQUIRY